Kynam Capital Management, LP Connect Biopharma Holdings LTD Transaction History

Kynam Capital Management, LP

  • $1.22 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$1.01 - $1.25 $206,690 - $255,805
-204,644 Reduced 27.67%
535,005 $604,000
Q2 2022

Aug 15, 2022
BUY
$0.56 - $3.25 $286,658 - $1.66 Million
511,890 Added 224.75%
739,649 $643,000
Q1 2022

May 13, 2022
BUY
$2.46 - $5.92 $560,287 - $1.35 Million
227,759 New
227,759 $688,000

Others Institutions Holding CNTB

# of Institutions
12
Shares Held
3.05M
Call Options Held
0
Put Options Held
0
View Full List

About Connect Biopharma Holdings Ltd

CNTB Quotes by TradingView
  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $53.9M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email